Literature DB >> 6317126

Correlation of changes in alpha 2-adrenoceptor number and locomotor responses to clonidine following clorgyline discontinuation.

C S Aulakh, R M Cohen, C McLellan, D L Murphy.   

Abstract

[3H]-clonidine binding in vitro and the locomotor response to clonidine in vivo were studied over an eight week period following four weeks of treatment with the monoamine oxidase-inhibiting antidepressant, clorgyline (1 mg kg-1 day-1). Long-term clorgyline administration caused decreases in responsiveness to clonidine and in the number of alpha 2-adrenoceptors; these changes reverted towards pretreatment values very gradually over an eight week period following discontinuation of the drug. This study provides some of the first detailed evidence regarding the slow return of adaptional changes following discontinuation of an antidepressant drug in animals and has implications for understanding some delayed drug interactions associated with MAO-inhibiting antidepressants in man.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317126      PMCID: PMC2044958          DOI: 10.1111/j.1476-5381.1983.tb11042.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Delayed recovery of sympathetic transmission following ten years monoamine oxidase inhibition.

Authors:  M J Cousins; J R Maltby
Journal:  Br J Anaesth       Date:  1971-08       Impact factor: 9.166

2.  Cumulative effects of irreversible MAO inhibitors in vivo.

Authors:  A E Felner; P C Waldmeier
Journal:  Biochem Pharmacol       Date:  1979-04-01       Impact factor: 5.858

3.  Monoamine oxidase: an approximation of turnover rates.

Authors:  C Goridis; N H Neff
Journal:  J Neurochem       Date:  1971-09       Impact factor: 5.372

4.  Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.

Authors:  D L Murphy; E Brand; T Goldman; M Baker; C Wright; D van Kammen; E Gordon
Journal:  J Nerv Ment Dis       Date:  1977-02       Impact factor: 2.254

5.  Duration of action of phenelzine in two patients.

Authors:  M Feinberg; J P de Vigne; Z Kronfol; E Young
Journal:  Am J Psychiatry       Date:  1981-03       Impact factor: 18.112

6.  Functional subsensitivity of alpha 2-adrenoceptors accompanies reductions in yohimbine binding after clorgyline treatment.

Authors:  R M Cohen; C S Aulakh; I C Campbell; D L Murphy
Journal:  Eur J Pharmacol       Date:  1982-06-16       Impact factor: 4.432

7.  Possible development of the serotonin syndrome in man.

Authors:  T R Insel; B F Roy; R M Cohen; D L Murphy
Journal:  Am J Psychiatry       Date:  1982-07       Impact factor: 18.112

8.  Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluation.

Authors:  S Lipper; D L Murphy; S Slater; M S Buchsbaum
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

9.  Changes in alpha- and beta-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants.

Authors:  R M Cohen; I C Campbell; M Dauphin; J F Tallman; D L Murphy
Journal:  Neuropharmacology       Date:  1982-04       Impact factor: 5.250

10.  REM sleep suppression induced by selective monoamine oxidase inhibitors.

Authors:  R M Cohen; D Pickar; D Garnett; S Lipper; J C Gillin; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  10 in total
  2 in total

1.  6-Hydroxydopamine pretreatment effects on alpha- and beta-adrenergic receptor adaptation to clorgyline.

Authors:  R M Cohen; C Aulakh; C McLellan; D L Murphy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

2.  The effects of acute and chronic desipramine on the thermogenic and hypoactivity responses to alpha 2-agonists in reserpinized and normal mice.

Authors:  D J Bill; I E Hughes; R J Stephens
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.